1. Home
  2. NVCR vs CCEC Comparison

NVCR vs CCEC Comparison

Compare NVCR & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CCEC
  • Stock Information
  • Founded
  • NVCR 2000
  • CCEC 2007
  • Country
  • NVCR Switzerland
  • CCEC Greece
  • Employees
  • NVCR N/A
  • CCEC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CCEC Marine Transportation
  • Sector
  • NVCR Health Care
  • CCEC Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • CCEC Nasdaq
  • Market Cap
  • NVCR 1.4B
  • CCEC 1.3B
  • IPO Year
  • NVCR 2015
  • CCEC 2007
  • Fundamental
  • Price
  • NVCR $14.04
  • CCEC $22.70
  • Analyst Decision
  • NVCR Buy
  • CCEC Buy
  • Analyst Count
  • NVCR 7
  • CCEC 1
  • Target Price
  • NVCR $28.79
  • CCEC $26.00
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • CCEC 11.9K
  • Earning Date
  • NVCR 10-30-2025
  • CCEC 11-07-2025
  • Dividend Yield
  • NVCR N/A
  • CCEC 5.29%
  • EPS Growth
  • NVCR N/A
  • CCEC 62.73
  • EPS
  • NVCR N/A
  • CCEC 4.04
  • Revenue
  • NVCR $630,160,000.00
  • CCEC $424,701,000.00
  • Revenue This Year
  • NVCR $6.68
  • CCEC $17.10
  • Revenue Next Year
  • NVCR $7.01
  • CCEC $13.73
  • P/E Ratio
  • NVCR N/A
  • CCEC $5.62
  • Revenue Growth
  • NVCR 14.58
  • CCEC 84.28
  • 52 Week Low
  • NVCR $10.87
  • CCEC $14.09
  • 52 Week High
  • NVCR $34.13
  • CCEC $24.83
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.46
  • CCEC 52.20
  • Support Level
  • NVCR $12.61
  • CCEC $21.21
  • Resistance Level
  • NVCR $14.77
  • CCEC $22.48
  • Average True Range (ATR)
  • NVCR 0.55
  • CCEC 0.90
  • MACD
  • NVCR 0.19
  • CCEC 0.02
  • Stochastic Oscillator
  • NVCR 67.68
  • CCEC 59.46

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CCEC Capital Clean Energy Carriers Corp. Common Share

Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.

Share on Social Networks: